Cargando…
Dose‐Related Adverse Drug Events in Neonates: Recognition and Assessment
The efficacy and safety of a drug is dose or exposure related, and both are used to assess the benefit‐risk balance of a given drug and ultimately to decide on the specific drug license, including its dose and indication(s). Unfortunately, both efficacy and safety are much more difficult to establis...
Autores principales: | Allegaert, Karel, van den Anker, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361661/ https://www.ncbi.nlm.nih.gov/pubmed/34185907 http://dx.doi.org/10.1002/jcph.1827 |
Ejemplares similares
-
Creatinine Trends to Detect Ibuprofen-Related Maturational Adverse Drug Events in Neonatal Life: A Simulation Study for the ELBW Newborn
por: van Donge, Tamara, et al.
Publicado: (2021) -
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
por: van den Anker, John N., et al.
Publicado: (2009) -
Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools
por: van den Anker, John, et al.
Publicado: (2019) -
Neonatal pain management: still in search of the Holy Grail
por: Allegaert, Karel, et al.
Publicado: (2016) -
Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs
por: Van den Anker, John N., et al.
Publicado: (2020)